CharlesrivP
The Immunotoxicology group supports the safety assessment of preclinical treatments and clinical sample analysis using cell-based assays, flow cytometry, and ELISpot. The role involves method development, validation, and routine sample analysis in both regulated and non-regulated environments. Team members operate specialized laboratory instruments and contribute to process improvement initiatives.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for CharlesrivP.
19% below the average for this role